Details for 2015154393

Up to date per 01.04.2026

Actions

Title / Product Name

Verwendung von TGF-beta-Antagonisten zur Behandlung von Kleinkindern mit dem Risiko der Entwicklung von bronchopulmonaler Dysplasie

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2015154393

EP Publication Number

2918288

E-Number

918452

Language

PCT Number

Publication Date

16.09.2015 A

16.08.2017 B1

Registration Date

16.08.2017

AT Publication Date

15.09.2017

Application Date

03.10.2007

Registration Number

Priorities

03.10.2006

827933 P

IPC

A61K 39/395 20060101AFI20150717BHEP

Maximum Duration of Protection

03.10.2027

Owner

Genzyme Corporation500 Kendall Street Cambridge, MA 02142US

The General Hospital CorporationMassachusetts General Hospital 55 Fruit Street Boston, MA 02114US

Representative

HÄUPL & ELLMEYER KG PATENTANWALTSKANZLEIMariahilfer Straße 501070 WienAT

Inventor

Streisand, James B.c/o Genzyme Corporation 500 Kendall Street Cambridge, Massachusetts 02142US

Roberts, Jesse D.21 Dustin Street Brighton, Massachusetts 02135US